6-Aminonicotinamide, powder_crystalline_pale yellow
Proveedor: MP Biomedicals
|
Peligro
|
Sinónimos:
6-Aminopyridine-3-carboxamide
0215010305
0215010301
ICNA0215010305EA
558
EUR
ICNA0215010305
ICNA0215010301
6-Aminonicotinamide, powder_crystalline_pale yellow
6-Aminonicotinamide
6-Aminonicotinamide was found to inhibit NADP+-dependent enzyme, 6-phosphogluconate dehydrogenase.
6-AN interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, like cisplatin, in killing cancer cells (IC50 = 0.5 mM). 6-AN also reduces cardiovascular oxidative injury following ischemia/reperfusion. In addition, 6-AN causes glial neurodegeneration.
Formula:
C₆H₇N₃O MW: 137.14 g/mol Temperatura de almacenaje: Ambiente |
Número MDL:
MFCD00006327 Núm. CAS: 329-89-5 EINECS: 206-349-7 |
Resultados test especificaciones
Identity Test | Passes |
FTIR | Conforms to Standard |
Melting Point | 240 - 250 °C |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...